Blog

Nov 06, 2024

Sirio splashes €16m on an automated nutraceutical packaging facility

Sirio Pharma has invested €16m into a purpose-built, automated packaging facility to serve the nutraceutical industry. The site near Berlin hosts bottling and blistering lines, which can support

Sirio Pharma has invested €16m into a purpose-built, automated packaging facility to serve the nutraceutical industry.

The site near Berlin hosts bottling and blistering lines, which can support clients looking for both bulk and private label supply.

With the opening of this novel facility, Sirio will be able to offer customers end-to-end capabilities in nutraceutical development and commercialisation.

Sirio's facility is designed to ensure that its softgels manufactured at the neighbouring site can be easily transferred and packaged in the same vicinity, while maintaining strict quality control protocols.

According to Sirio, its bottling line is fully automated — incorporating an additional robot for palletisation.

The line is estimated to produce 5 million bottles annually, and can accomodate bottle sizes between 75 and 400mL.

The second line, which is responsible for packaging softgels, can fill 20 million blister packs annually across ten different formats.

With this addition, the site has a bulk production capacity of 2 billion capsules per year.

The products produced are also at GMP standards, with production to delivery times starting at three weeks.

To guarantee stringent quality control, the packaging lines are fitted with advanced visual inspection systems and in-line process control technologies. These systems monitor parameters such as physical appearance, product weight and metal detection.

Sirio's General Manager for Europe & Americas, Sara Lesina, commented: “We have grown significantly in recent years and, as a result, have doubled down on investing in advanced manufacturing technology."

"With our packaging facility, we now offer full-service, pharmaceutical-grade softgel development in Germany. Our teams bring incredible experience, spanning over 30 years, and by completing everything from R&D to final packaging on a single site, we offer significant advantages to our customers, who benefit from pharma-grade quality at every phase of production,”

The new investment is enhanced further by its environmental credentials, with the facility supported by energy-saving heat pumps, energy recovery technology and solar panels.